QQ客服 官方微博 反馈留言

	Novel compounds TAD-1822-7-F2 and F5 inhibited HeLa cells growth through the JAK/Stat signaling pathway
	Yang, Tianfeng; Shi, Xianpeng; Kang, Yuan; Zhu, Man; Fan, Mengying; Zhang, Dongdong; Zhang, Yanmin
刊名	BIOMEDICINE & PHARMACOTHERAPY
	2018
卷号	103页码:118-126
关键词	Surface plasmon resonance HeLa Quartz crystal microbalance TAD-1822-7-F2 and F5 JAK/Stat
ISSN号	0753-3322
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2917301
专题	西安交通大学
推荐引用方式 GB/T 7714	Yang, Tianfeng,Shi, Xianpeng,Kang, Yuan,et al. Novel compounds TAD-1822-7-F2 and F5 inhibited HeLa cells growth through the JAK/Stat signaling pathway[J]. BIOMEDICINE & PHARMACOTHERAPY,2018,103:118-126.
APA	Yang, Tianfeng.,Shi, Xianpeng.,Kang, Yuan.,Zhu, Man.,Fan, Mengying.,...&Zhang, Yanmin.(2018).Novel compounds TAD-1822-7-F2 and F5 inhibited HeLa cells growth through the JAK/Stat signaling pathway.BIOMEDICINE & PHARMACOTHERAPY,103,118-126.
MLA	Yang, Tianfeng,et al."Novel compounds TAD-1822-7-F2 and F5 inhibited HeLa cells growth through the JAK/Stat signaling pathway".BIOMEDICINE & PHARMACOTHERAPY 103(2018):118-126.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。